While Novartis holds a diversified product portfolio, there is some product concentration with its largest drugs, Entresto (close to 15% of sales) and Cosentyx (close to 10% of sales). Both drugs will ...

Pharmaceutical Executive recently spoke with RheumaGen CEO Richard Freed about his career and the work the biotech is doing ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

Neurodegenerative diseases, such as Alzheimer’s and multiple sclerosis, can also be exacerbated by inflammation ... professor of exercise immunology at Loughborough University, adding that chronic ...

Ruth Arnon, Weizmann’s Paul Ehrlich professor of immunology, has been researching ... Michael Sela, with whom she developed the multiple sclerosis treatment drug Copaxone. She served as vice president ...

Researchers at the University of Pittsburgh and Carnegie Mellon University collaborated to create a customized app based on ...

A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of ...

Most people with MS who are treated with formulations of botulinum toxin to manage spasticity report being satisfied, a study ...

U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...

Autoimmune diseases, like multiple sclerosis result when the body’s immune system starts to attack its own cells. Regulatory ...